Formulation development, in-vitro and ex-vivo evaluation of dry adsorbed solid lipid nanoparticles: an approach of overcoming olanzapine drawbacks Cover

.blurhash-client-img { display: none !important; }

Formulation development, in-vitro and ex-vivo evaluation of dry adsorbed solid lipid nanoparticles: an approach of overcoming olanzapine drawbacks

European Pharmaceutical Journal

Volume 71 (2024): Issue 1 (August 2024)

By: Rajashree Hirlekar, Alfiha Momin and Srinivas Bhairy

Open Access

|Apr 2024

Authors

Rajashree Hirlekar

rajashree.hirlekar@ves.ac.in

Vivekanand Education Society’s College of Pharmacy, Mumbai, INDIA

Alfiha Momin

Vivekanand Education Society’s College of Pharmacy, Mumbai, INDIA

Srinivas Bhairy

Vivekanand Education Society’s College of Pharmacy, Mumbai, INDIA

DOI: https://doi.org/10.2478/afpuc-2024-0004 | Journal eISSN: 2453-6725

Journal RSS Feed

Language: English

Page range: 1 - 15

Submitted on: Apr 5, 2023

Accepted on: Aug 29, 2023

Published on: Apr 20, 2024

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Hepatic metabolism,

Solid lipid nanoparticles,

Dry adsorbed nanoparticles,

Lymphatic uptake,

Oral bioavailability

Related subjects:

Pharmacy, other

© 2024 Rajashree Hirlekar, Alfiha Momin, Srinivas Bhairy, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 71 (2024): Issue 1 (August 2024)Next article